Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Physiological Research|April 6, 2017
Molecular genetic background of an autosomal dominant hypercholesterolemia in the Czech RepublicL Tichý, L Fajkusová, P Zapletalová, et al.
Human Mutation|December 19, 2001
Cystathionine beta-synthase deficiency in Central Europe: discrepancy between biochemical and molecular genetic screening for homocystinuric allelesJ Sokolová, B Janosíková, J D Terwilliger, et al.
Human Mutation|August 29, 2001
Spectrum of low density lipoprotein receptor mutations in Czech hypercholesterolemic patientsV Kuhrová, H Francová, P Zapletalová, et al.
Casopis Lekaru Ceskych|March 19, 1999
[Direct detection of mutations in the LDL receptor gene in patients with familial hypercholesterolemia]T Freiberger, V Kuhrová, L Kozák, et al.
Journal of Reproductive Immunology|May 11, 2010
No association of FCRN promoter VNTR polymorphism with the rate of maternal-fetal IgG transferT Freiberger, B Ravcuková, L Grodecká, et al.
Clinical Immunology (Orlando, Fla.)|July 15, 2010
Association of FcRn expression with lung abnormalities and IVIG catabolism in patients with common variable immunodeficiencyT Freiberger, L Grodecká, B Ravcuková, et al.
Physiological Research|April 6, 2017
Familial hypercholesterolemia in the Czech Republic: more than 17 years of systematic screening within the MedPed projectM Vrablík, M Vaclová, L Tichý, et al.
Bratislavske Lekarske Listy|December 30, 2021
Effect of immunosuppressive therapy in inflammatory cardiomyopathy: data from The Czech Inflammatory Cardiomyopathy Immunosuppressive TrialH Poloczkova, J Krejci, P Hude, et al.
Clinical and Experimental Immunology|July 19, 2008
Mannose-binding lectin gene polymorphic variants predispose to the development of bronchopulmonary complications but have no influence on other clinical and laboratory symptoms or signs of common variable immunodeficiencyJ Litzman, T Freiberger, B Grimbacher, et al.
Human Immunology|August 14, 2012
Sequence variants of the TNFRSF13B gene in Czech CVID and IgAD patients in the context of other populationsT Freiberger, B Ravčuková, L Grodecká, et al.
Pageof 4